The first randomized trial of medical #AI to show it saves lives
ECG-AI alert in 16,000 hospitalized patients
31% reduction of mortality (absolute 7 per 100 patients) in pre-specified high-risk group
nature.com/articles/s4159…
Nature Medicine

Advances in bioengineering and organic chemistry have enabled targeting of the previously ‘undruggable’ #KRAS ; our latest review from Eileen M O’Reilly & colleagues discusses the successes, challenges & future of KRAS therapeutics in #cancer
Memorial Sloan Kettering Cancer Center
nature.com/articles/s4159…

Hello! I've written a piece for the Guardian about childbirth and the illness that's transformed my body and life forever. There are some jokes in it though! I think. X

📢 Proud to see this important, timely comment by Dr. Laura Esserman & Douglas Yee MD just published in Nature Medicine. I 💯 agree: Science & medical groups should stop holding conferences in anti-choice states. Abortion IS healthcare! #WomensRights
Please RT!
nature.com/articles/s4159…

Nature Cancer has THREE positions open!! 📢

Let me know if you have any questions about Nature Portfolio editorial life. I'm happy to chat on twitter/email/video call.

P.S. A locum position is a really great way to decide if an editorial career is for you!!

#OpenAccess in Nature Medicine
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
nature.com/articles/s4159…
Fantastic study that uses tens of thousands of cytology cases for training & test sets for assessing CUP patients.

Pediatric precision medicine has been transformed by genetics, omics profiling, and AI advancements. Join The Hospital for Sick Children (SickKids) nature natureMEdicine and a great panel of experts for presentations exploring what new optimal care looks like. Limited seats!
🎟️go.nature.com/4cYTeEh

As part of our Series on #SexDifferences in cancer, Berna Özdemir Universität Bern summarises the evidence for greater drug toxicity observed in female patients & emphasizes the need for increased awareness of sex differences at all stages of drug development. go.nature.com/4an1Q62

Few things are as inevitable as the word “battle” appearing in the obituary for a patient who died of cancer

But we need to reframe the disease in a manner that does not imply cowardice or ignobility for level-headed refusal of treatment

theoncologist.onlinelibrary.wiley.com/doi/full/10.16…

Call for Abstracts! Share your groundbreaking research on the intersection of bench to bedside immunotherapy at the @Natureconf Cancer Immunotherapy we are organizing in #Boston June 10-12, 2024. The deadline to submit is April 12! go.nature.com/3PDL8XR

📢Come join our Nature Cancer editorial team!
We're hiring an Associate/Senior Editor in our Shanghai, Beijing, New York or Philadelphia offices🌎.

Application deadline April 28th🗓️
Please spread the word‼️

Find details here:
nature.com/naturecareers/…

NEW content online! Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets dlvr.it/T3R0pS

In the phase 2 HUDSON study, patients with advanced non-small cell lung cancer received anti-PDL1 combined with biomarker guided therapies, leading to benefit in response to the combination ATR kinase inhibitor ceralasertib + durvalumab Benjamin Besse nature.com/articles/s4159…

Integration of clinical and #proteomic data from #tumour tissues in patients with pancreatic ductal adenocarcinoma #PDAC identified a prognostic risk model for patient stratification as well as biomarkers of response to adjuvant chemotherapy.
nature.com/articles/s4159…

We're thrilled to announce Dana-Farber Nature Cancer Nature Medicine Nature Immunology Nature Rev Immunol have partnered for an amazing event in #Boston
This event will discuss recent biological, clinical, and translational advances in the field
Get your tix today🎟️go.nature.com/CancerImm

Happy to report ctDNA analysis of PARADIGM Nature Medicine. Negative hyper selection enriched benefit of pani for CRC regardless of sidedness. Tumor location serve as surrogate for molecular type? Nature Portfolio ESMO - Eur. Oncology ASCO Takeda Oncology OncoAlert
nature.com/articles/s4159…

So exciting to hear that our review was the top downloaded article in 2023 in Nature Reviews Cancer. Was great to write this with my postdoc Antoinette van Weverwijk.The Netherlands Cancer Institute Oncode Institute. Interested in cancer cell - immune cell crosstalk? enjoy reading! Thanks Nature Reviews Cancer!

new out in Nature, mechanobiology meets cancer nature.com/articles/s4158…

Online now! Metabolic heterogeneity in cancer dlvr.it/T1plRG

📰 Hot off the press in Nature Medicine and very timely: A case report of T cell #lymphoma following anti-CD19 #CARTcells appears to not be due to CAR insertional mutagenesis. Also included -- an analysis of SPMs at @UPennMedicine. Work led by Marco Ruella nature.com/articles/s4159…